X0306 4 2021-12-03 0001835567 Pear Therapeutics, Inc. PEAR 0001881044 Lynch Zack C/O PEAR THERAPEUTICS, INC. 200 STATE STREET, 13TH FLOOR BOSTON MA 02109 1 0 0 0 Class A Common Stock 2021-12-03 4 A 0 1084914 A 1084914 I by JAZZ Human Performance Opportunity Fund, L.P. Class A Common Stock 2021-12-03 4 A 0 9671673 A 9671673 I by JAZZ Human Performance Technology Fund, L.P. Class A Common Stock 2021-12-03 4 A 0 10000 10.00 A 9681673 I by JAZZ Human Performance Technology Fund, L.P. Stock Option (Right to Buy) 0.02 2021-12-03 4 A 0 29448 A 2025-01-21 Common Stock 29448 29448 D Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 736,827 shares of preferred stock of Private Pear previously held by JAZZ Human Performance Opportunity Fund, L.P. Received in accordance with the terms of the Business Combination Agreement in exchange for 6,568,585 shares of preferred stock of Private Pear previously held by JAZZ Human Performance Technology Fund, L.P. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of the Reporting Person's pecuniary interest therein. On June 21, 2021, Issuer entered into subscription agreements with certain investors (the "PIPE Investors") pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $10.00 per share in connection with, and conditioned upon, the substantially concurrent consummation of certain transactions, including the Business Combination. As one of the PIPE Investors, on December 3, 2021, JAZZ Human Performance Technology Fund, L.P. acquired 10,000 shares of Issuer common stock for $10.00 per share. 100% of the shares subject to this option are fully vested and exercisable. Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 20,000 shares of common stock of Private Pear for $0.02 per share. /s/ Stacie S. Aarestad, Attorney-in-Fact 2021-12-07